Hims & Hers Stock: 49% Growth, 17-Point Margin Drop

Hims & Hers Health reported 49% revenue growth in the third quarter of 2026, reaching approximately $890 million. For a business already generating hundreds of millions in quarterly revenue, that represents substantial expansion.

However, several other figures tell a more complicated story. Subscribers increased 13%, gross margin declined from 74% to 57%, and the company reported a net loss of $33 million compared with a profit a year earlier.

Those developments are not necessarily contradictory. A business can grow rapidly while changing the products it sells, the customers it serves and the costs required to deliver those products.

For long-term investors, the important question is whether that growth is creating increasingly attractive economics or simply making the business larger.

Revenue increased 49%, but subscriber growth was much slower

According to Hims & Hers' November 9 earnings release, quarterly revenue increased from $599 million to $890.4 million.

The number of subscribers reached approximately 2.79 million, compared with 2.47 million a year earlier. That represents growth of 13%.

At the same time, monthly revenue per average subscriber increased from $81 to $105, or approximately 30%.

These figures show that revenue expansion was not explained by customer-count growth alone.

Hims & Hers is generating more reported revenue relative to its average subscriber base, partly because customers are purchasing a different mix of treatments and services.

However, this does not automatically mean existing customers increased their spending by 30%. The metric is calculated using total revenue and average subscribers, and can be influenced by acquisitions, customer composition, product mix and revenue recognition.

That distinction matters because increasing monetization per subscriber and improving customer retention are different sources of economic value.

What revenue per subscriber actually measures

Hims & Hers calculates monthly revenue per average subscriber by dividing total quarterly revenue by average subscribers and then dividing by three months.

Average subscribers are calculated using the subscriber counts at the beginning and end of the period.

The company defines subscribers as customers with qualifying recurring subscriptions. Customers making only one-time purchases are excluded from the subscriber count.

That creates an important analytical limitation.

Because the numerator includes total revenue while the denominator reflects a defined subscriber population, the metric should not be interpreted as a precise measure of what a typical existing customer spent.

It is an aggregate monetization measure rather than a direct measure of same-customer spending growth.

For investors, three questions are worth separating. Is the company attracting more subscribers? Are existing subscribers purchasing more valuable products or services? And is the company earning an attractive contribution from those additional purchases?

Hims & Hers currently provides encouraging evidence for revenue expansion, but the latest results show that the profitability of that expansion deserves closer examination.

International expansion explains an important part of growth

The geographic breakdown provides additional context.

United States revenue increased 21% to $657.1 million. Revenue outside the United States increased 321% to $233.3 million.

The difference is substantial, particularly because international revenue now represents approximately 26% of quarterly sales.

However, the international growth rate does not represent purely organic expansion.

In its third-quarter Form 10-Q, the company explains that international revenue growth was primarily driven by geographic expansion through acquisitions, including Eucalyptus, which was acquired in June 2026.

Hims & Hers also acquired Zava in 2025 and expanded into additional markets through other transactions.

Those acquisitions added operations, customers, products and revenue that were not included in the same way during the comparable prior-year period.

That does not make the additional revenue less valuable. Successful acquisitions can create substantial shareholder value when they strengthen the underlying business and generate attractive returns on the capital invested.

But it does mean investors should distinguish growth generated by the existing business from growth resulting from businesses acquired during the year.

Eucalyptus adds scale, but acquisitions have a cost

Hims & Hers completed its acquisition of Eucalyptus on June 2, 2026.

The transaction expanded the company's presence across Australia, the United Kingdom, Germany, Japan and Canada, among other markets.

The acquisition also changed the financial structure of the business.

Hims & Hers disclosed an accounting purchase price of approximately $968.5 million. This included $225 million of upfront cash, approximately $683.9 million of deferred payments and contingent consideration valued at roughly $59.6 million at acquisition.

Those obligations matter when evaluating whether the acquired revenue ultimately creates shareholder value.

An acquisition can immediately increase consolidated revenue because the acquired business becomes part of the financial statements.

The economic return, however, depends on the future cash generated by that business relative to the total purchase consideration and integration costs.

Investors therefore need to evaluate acquisitions using more than their contribution to reported revenue growth.

The relevant questions include how profitable the acquired operations are, what additional investment they require and whether the combined business can eventually earn attractive returns on the capital committed.

The most important change may be in gross margin

Hims & Hers' gross margin declined from 74% in Q3 2025 to 57% in Q3 2026.

That represents a decrease of 17 percentage points in a single year.

The underlying figures help explain the magnitude of the change.

• Revenue: Increased 49%, from $599 million to $890.4 million.
• Cost of revenue: Increased 143%, from $156.9 million to $381.2 million.
• Gross profit: Increased 15%, from $442.1 million to $509.2 million.
• Gross margin: Declined from 74% to 57%.

Revenue increased by approximately $291 million, but gross profit increased by only $67 million.

That means the additional reported revenue produced a much smaller increase in gross profit than the headline growth rate might initially suggest.

The incremental gross profit represented approximately 23% of the increase in revenue during the year-over-year comparison.

This is not a standalone estimate of the profitability of every new customer or product. Acquisitions, pricing, product mix and other changes all influence the comparison.

Nevertheless, it illustrates an important economic development. Hims & Hers is generating substantially more revenue, but the direct costs associated with generating that revenue have increased even faster.

Why the treatment mix matters

Hims & Hers offers products and services across weight loss, dermatology, sexual health and other healthcare categories.

These offerings do not necessarily have comparable gross margins.

The company explained in its quarterly filing that the decline in gross margin was primarily associated with weight-loss offerings, shorter shipping cadences, increased fulfillment costs, international expansion and recent acquisitions.

Some products require more expensive medication, packaging, medical services or shipping arrangements.

A growing contribution from these products can therefore increase average revenue per subscriber while simultaneously reducing the percentage of that revenue retained as gross profit.

Consider a simplified example.

A company initially sells a subscription generating $80 per month at a 75% gross margin. It retains $60 of gross profit before operating expenses.

Suppose it introduces another offering generating $120 per month at a 50% gross margin. That product also generates $60 of gross profit.

Revenue per customer increases by 50%, but gross profit per customer does not improve.

The higher-revenue product may still create value through better retention, additional cross-selling opportunities or lower acquisition costs over time.

However, the revenue increase alone does not demonstrate stronger unit economics.

This is why product mix matters when interpreting Hims & Hers' growing revenue per subscriber.

Lower margins are not automatically evidence of a weaker strategy

A declining gross margin is worth investigating, but it does not automatically mean the company is pursuing unattractive growth.

Some lower-margin products may address larger markets, attract customers who subsequently purchase additional services or improve retention through more comprehensive treatment programs.

In those situations, accepting lower gross margins could still create long-term shareholder value.

The important question is whether the additional contribution from those products eventually compensates for their higher delivery costs and the investments required to attract customers.

Management expects gross margins to remain below historical comparison periods in the near term, partly because of changes in its weight-loss offering and recent international acquisitions.

The company also expects greater scale, integration and purchasing efficiencies to support gross-margin stabilization over the longer term.

Those expectations provide a useful framework for future analysis, but they are not yet evidence that the anticipated improvements have been achieved.

Investors should look for actual improvements in product-level economics and cash generation as the international business becomes more established.

Operating expenses provide a different perspective

The company also made progress in reducing certain operating costs relative to revenue.

Marketing expenses increased only 7% year over year to approximately $247 million, substantially slower than revenue growth.

As a percentage of revenue, marketing declined from approximately 39% to 28%.

That is meaningful because customer acquisition is an important expense for a consumer healthcare platform.

However, lower marketing expenses as a percentage of revenue do not automatically establish that acquiring an individual customer has become cheaper.

Acquisitions, product mix and revenue per customer can affect the denominator, while marketing expenses reflect spending across different channels and periods.

Investors should therefore distinguish improving marketing leverage from improving customer acquisition economics.

Other operating expenses increased more rapidly. Technology and development spending rose 71%, while general and administrative expenses increased 88%.

Those costs reflect investments in technology, personnel, acquisitions and the broader organization.

Some may support future growth. Others may become recurring expenses that need to be covered by the company's gross profit.

The challenge is determining whether those investments eventually generate sufficient incremental economic value.

Cash flow has not followed revenue growth

The difference between growth and cash generation becomes particularly clear further down the financial statements.

Hims & Hers reported $65.4 million of operating cash flow during Q3, compared with $148.7 million a year earlier.

Free cash flow declined from $79.4 million to $26 million.

That represents a decline of approximately 67% in quarterly free cash flow despite revenue increasing 49%.

The company also reported a GAAP net loss of $33 million, compared with net income of $15.8 million in the prior-year quarter.

Adjusted EBITDA remained positive at $82.4 million, compared with $78.4 million a year earlier.

These figures measure different aspects of the business, and the decline in free cash flow should not be treated as a direct measure of the profitability of newly acquired customers.

Cash flow can be affected by working capital, investment timing, acquisition integration and other changes.

Nevertheless, the comparison reinforces the need to evaluate revenue growth alongside the economic resources that ultimately remain after operating and investment requirements.

Does Hims & Hers have a competitive advantage?

Hims & Hers is building a broader platform around recurring healthcare relationships, digital customer acquisition, treatment access and integrated fulfillment.

These capabilities could eventually create advantages through customer familiarity, more convenient service delivery and stronger ongoing relationships.

Potential sources of advantage might include brand recognition, switching costs and other forms of economic moat.

However, a recognizable brand and a growing subscriber base are not sufficient proof of a durable competitive advantage.

Customers may have alternatives, healthcare offerings are subject to regulatory requirements, and the company must continue demonstrating that its customer relationships generate attractive economics.

MOATEY currently gives Hims & Hers 6 of 20 available Moat points.

Its current Earnings Power Value versus Net Reproduction Value assessment shows EPV below NRV, while the historical moat trend is improving.

This is mixed evidence. The trend is becoming more favorable, but the framework does not yet identify sufficiently strong evidence of a durable economic advantage.

That distinction is important when evaluating a business expanding into new treatment categories and international markets.

Scale may create opportunities for competitive advantage. Investors still need evidence that those opportunities translate into sustainable economic returns.

MOATEY's latest assessment reflects the tension

MOATEY's latest assessment, updated November 10, classifies Hims & Hers as a Fast Grower and assigns a Poor rating.

The overall assessment is 28.9 out of 95.

The underlying components are:

• Fundamentals: 17.0/65
• Growth: 11.0/15
• Financial Health: 0.0/15
• Management: 0.0/15
• Moat: 6.0/20
• Valuation: 11.9/30

These figures reveal a substantial difference between historical growth and the other elements of the company's financial profile.

MOATEY currently records five-year revenue growth of 54.77% and earnings growth of 27.16%, both contributing positively to its Growth assessment.

However, its current adjusted free-cash-flow growth measure is negative 18.31%, contributing no points to the Growth assessment.

The latest MOATEY update also produced several noteworthy Events.

The classification changed from No Grower to Fast Grower. The earnings-growth measure moved from negative 30.57% to positive 27.16%, while the free-cash-flow growth measure moved from positive 31.78% to negative 18.31%.

These are changes in the framework's historical assessments following a data refresh. They should not be interpreted as equivalent to a sudden deterioration or improvement in the company's operations during a single day.

The current Financial Health and Management assessments are also weak. These are model-based observations rather than definitive judgments about the company's ability to meet every obligation or the competence of individual executives.

MOATEY currently identifies minor risks relating to historical shareholder dilution, debt repayment capacity based on its free-cash-flow assessment and insufficient evidence of a clear competitive advantage.

The systematic methodology and supporting research can be examined in the MOATEY factsheet and documentation.

Valuation requires a separate assessment

Hims & Hers' strong historical revenue growth does not automatically establish that its shares are attractively valued.

MOATEY currently records 11.9 out of 30 Valuation points. Its normal-case discounted-cash-flow estimate is approximately $17.26 per share, compared with a reference market price of approximately $18.58 at the latest update.

The model therefore does not currently identify a positive margin of safety under its normal-case assumptions.

These figures are model estimates rather than price targets or predictions. They depend on assumptions about future cash generation, growth, discount rates and terminal value.

Valuation is particularly sensitive when a company is growing rapidly while the composition and profitability of its revenue are changing.

Higher future revenue may create substantial value if the company can eventually generate attractive margins and free cash flow.

But if delivering that revenue continues requiring higher direct costs, additional acquisitions or substantial reinvestment, the resulting economic value may be considerably lower than the headline growth rate suggests.

For investors, the central question is not whether Hims & Hers can continue expanding. It is how much profitable cash generation that expansion can ultimately support.

What investors should watch next

The first consideration is subscriber growth. Hims & Hers ended September with approximately 2.79 million subscribers, compared with 2.89 million at the end of June.

That sequential decline deserves attention, although it does not establish a particular churn rate. Changes in acquisition integration, subscription definitions, customer transitions and product offerings can influence reported subscriber counts.

The second is revenue per average subscriber. Continued increases may indicate stronger monetization, but investors should determine whether those increases reflect organic customer behavior, higher-value treatments or changes in the acquired business mix.

Third, gross-margin development will be important. Management expects the margin to remain below historical levels in the near term. Evidence of stabilization or improvement would help investors assess whether the current product mix can support attractive economics at scale.

Fourth, international revenue should be evaluated separately from acquisition contributions. Growth through newly consolidated businesses is economically different from growth generated by an established operation.

Finally, operating cash flow and free cash flow deserve particular attention. Revenue can expand rapidly, but long-term shareholder value depends on the cash ultimately generated after funding the business and its required investments.

The larger lesson for investors

Hims & Hers' latest quarter demonstrates why revenue growth needs to be separated into its underlying economic components.

The company generated 49% more revenue, supported by international expansion, acquisitions and a changing treatment mix. Those developments show that the business is expanding considerably.

However, subscriber growth was much slower, gross margin declined by 17 percentage points and free cash flow fell substantially.

Those observations do not mean the strategy cannot create value. Lower-margin products and international acquisitions may eventually support stronger customer relationships, greater scale and additional profitable opportunities.

But the evidence needs to develop beyond revenue growth alone.

For long-term investors, a business becoming larger is not the same as a business becoming economically stronger.

The more useful question is how much additional value remains after the company pays the costs of delivering that growth.